Rui Su Selected Research

Cations

12/2021

Targeting SOS1 overcomes imatinib resistance with BCR-ABL independence through uptake transporter SLC22A4 in CML.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rui Su Research Topics

Disease

50	Neoplasms (Cancer) 02/2024 - 04/2015
21	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024 - 11/2015
14	Leukemia 02/2024 - 10/2015
11	Infections 04/2024 - 12/2015
9	Carcinogenesis 01/2024 - 01/2018
6	Neoplasm Metastasis (Metastasis) 02/2024 - 04/2015
6	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 01/2019
6	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 01/2021
5	Stomach Neoplasms (Stomach Cancer) 10/2023 - 04/2015
5	Inflammation (Inflammations) 01/2023 - 01/2014
4	Breast Neoplasms (Breast Cancer) 02/2024 - 01/2018
4	Obesity 01/2024 - 01/2014
4	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 08/2010
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2023 - 01/2020
4	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2018
3	Liver Diseases (Liver Disease) 04/2024 - 01/2020
3	Pain (Aches) 12/2023 - 11/2012
3	Autoimmune Diseases (Autoimmune Disease) 11/2023 - 01/2021
3	Virus Diseases (Viral Diseases) 11/2023 - 11/2019
3	Arthritis (Polyarthritis) 01/2023 - 01/2022
3	Rheumatoid Arthritis 01/2022 - 01/2020
3	Neuroblastoma 09/2021 - 12/2019
2	Disease Progression 04/2024 - 01/2020
2	Gout 01/2024 - 01/2023
2	Pathologic Processes 01/2024 - 01/2023
2	Dermatomyositis (Dermatopolymyositis) 11/2023 - 11/2022
2	Type 2 Diabetes Mellitus (MODY) 08/2023 - 10/2019
2	Pneumonia (Pneumonitis) 01/2023 - 01/2022
2	Diabetes Complications 01/2023 - 01/2021
2	Hypoxia (Hypoxemia) 01/2023 - 09/2021
2	Hyperventilation 11/2022 - 11/2021
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2021
2	Triple Negative Breast Neoplasms 01/2022 - 01/2021
2	Dysbiosis 01/2022 - 01/2022
2	Liver Failure 01/2022 - 02/2017
2	T-Cell Leukemia (Leukemia, T Cell) 01/2022 - 01/2021
2	Human Influenza (Influenza) 01/2022 - 11/2017
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 09/2021 - 07/2021
2	Cognitive Dysfunction 07/2021 - 10/2019
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2021
2	Glioma (Gliomas) 12/2020 - 06/2020
2	Brain Neoplasms (Brain Tumor) 01/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

17	6-methyladenineIBA 01/2024 - 01/2017
16	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2016
15	Proteins (Proteins, Gene)FDA Link 01/2024 - 11/2015
13	N-methyladenosineIBA 01/2024 - 01/2017
8	Messenger RNA (mRNA)IBA 01/2024 - 01/2018
7	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2020
6	Interleukin-2 (IL2)IBA 01/2024 - 01/2020
6	MicroRNAs (MicroRNA)IBA 01/2024 - 04/2015
5	Antiviral Agents (Antivirals)IBA 04/2024 - 11/2020
5	CytokinesIBA 01/2024 - 01/2020
5	Alpha-Ketoglutarate-Dependent Dioxygenase FTOIBA 01/2023 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 01/2020
4	Arginine (L-Arginine)FDA Link 02/2024 - 01/2022
4	Therapeutic UsesIBA 01/2024 - 01/2021
4	Imatinib Mesylate (Gleevec)FDA Link 08/2023 - 12/2021
4	MethyltransferasesIBA 06/2022 - 01/2018
4	CateninsIBA 01/2021 - 04/2015
3	AntibodiesIBA 04/2024 - 01/2017
3	Insulin (Novolin)FDA Link 02/2024 - 12/2020
3	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2022
3	Interleukin-6 (Interleukin 6)IBA 11/2023 - 11/2019
3	Carrier Proteins (Binding Protein)IBA 11/2023 - 01/2020
3	Glucose (Dextrose)FDA LinkGeneric 08/2023 - 01/2014
3	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 05/2015
3	Amyloid (Amyloid Fibrils)IBA 09/2021 - 12/2019
3	VaccinesIBA 01/2021 - 01/2017
3	Long Noncoding RNAIBA 01/2020 - 01/2019
2	Interferon Type IIBA 02/2024 - 11/2020
2	Phenylalanine (L-Phenylalanine)FDA Link 02/2024 - 01/2023
2	Silver Sulfadiazine (SSD)FDA LinkGeneric 02/2024 - 01/2021
2	Inositol (Myoinositol)IBA 01/2024 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2023 - 07/2020
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2023 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 12/2014
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023 - 10/2019
2	Uric Acid (Urate)IBA 01/2023 - 08/2018
2	LipopolysaccharidesIBA 01/2023 - 01/2023
2	AcidsIBA 01/2023 - 01/2022
2	ginsenoside M1IBA 12/2022 - 01/2022
2	Lactic Acid (Lactate)FDA LinkGeneric 11/2022 - 01/2022
2	Carbon DioxideIBA 11/2022 - 11/2021
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2022 - 05/2015
2	Caspase 3 (Caspase-3)IBA 08/2022 - 11/2019
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2014
2	BilirubinIBA 01/2022 - 10/2019
2	LigandsIBA 01/2022 - 09/2021
2	Neuroprotective AgentsIBA 09/2021 - 10/2019
2	AntioxidantsIBA 09/2021 - 01/2020
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021 - 06/2020
2	AutoantibodiesIBA 01/2021 - 01/2020
2	Nerve Growth Factor (NGF)IBA 02/2020 - 12/2019

Therapy/Procedure

24	Therapeutics 02/2024 - 05/2015
8	Drug Therapy (Chemotherapy) 01/2023 - 04/2015
5	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2023 - 01/2017
4	Immunotherapy 01/2023 - 01/2021
2	Critical Care (Surgical Intensive Care) 02/2024 - 04/2022
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 08/2023 - 12/2017
2	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 01/2023 - 08/2018